Theranos’ Holmes May Pursue ‘Mental Disease’ in Her Defense
- Ex-CEO charged with fraud turns to expert on violence, trauma
- Judge rules Holmes must also be examined by government experts
This article is for subscribers only.
Former Theranos Inc. Chief Executive Officer Elizabeth Holmes is exploring a “mental disease” defense for her criminal fraud trial, in one of Silicon Valley’s most closely watched cases.
That possibility was revealed Wednesday when the judge overseeing the case ruled that government prosecutors can examine Holmes. The ruling was in response to the failed blood-testing startup founder’s plan to introduce evidence of “mental disease or defect” or other mental condition “bearing on the issue of guilt,” according to the filing.
Holmes may be seeking to introduce the evidence to challenge the requirement that prosecutors prove her intent to do something wrong or illegal.